Harlequin banding and localisation of sister-chromatid exchanges.
Harlequin banding (HB) was standardised on Indian muntjac chromosomes by superimposing harlequin staining or sister-chromatid differentiation and G-banding after incorporation of bromodeoxyuridine (BrdU) or cholorodeoxyuridine (CldU), and after treatment with BrdU plus mitomycin C (MMC). SCEs were localized on these chromosomes with the aid of the G-band map. There were more SCEs in G-bands than in R-bands in BrdU-incorporated chromosomes. CldU-incorporated chromosomes, however, did not show a preferential localization of SCEs in either G- or R-bands. When BrdU + MMC-induced SCEs were localized in harlequin-banded chromosomes, there was a significantly greater number of SCEs in R-bands; and there was a concomitant reduction in the frequency of SCEs in G-bands, as compared to the SCEs observed in this region after BrdU incorporation alone. Centromeric regions of chromosomes 1 and X had preferred sites for occurrence of SCEs in BrdU-incorporated chromosomes, the preferred sites being more in G-bands after BrdU and CldU incorporation and in R-bands after treatment of BrdU-incorporated chromosomes with MMC. Thus the formation of SCEs is not restricted by structure per se as defined by euchromatin or heterochromatin, but depends on the site of lesion production, type of lesion and repair pathway followed.
Rachel
A J
AJ
Cytogenetics Laboratory, Banaras Hindu University, Varanasi, India.
Sharma
T
T
Menon
V V
VV
D000818:Animals; D001973:Bromodeoxyuridine / Q000494:pharmacology; D002871:Chromosome Banding / Q000379:methods*; D003670:Deer / Q000235:genetics; D003857:Deoxyuridine / Q000031:analogs & derivatives / Q000494:pharmacology; D066298:In Vitro Techniques; D008677:Metaphase; D016685:Mitomycin / Q000494:pharmacology; D012854:Sister Chromatid Exchange
C012244:5-chloro-2'-deoxyuridine; D016685:Mitomycin; D001973:Bromodeoxyuridine; D003857:Deoxyuridine